Compleo Advisors is a rare disease strategy and creative firm. We work with rare disease biotechs, advocacy organizations, and pharma marketing services companies at moments of inflection: when the market has shifted, an asset has advanced, or the business has outgrown its current strategy. What you get is a partner who knows this field from the inside: sharper direction, positioning that differentiates, and the market movement to drive progress.
Who we work with
Each engagement begins with a diagnostic. Where you go from there depends on where you are.
Your science is ready to move. What you need now is sharper positioning, a market narrative that earns credibility with the stakeholders who matter, and advocacy relationships that are intentional from the start.
Explore biotech servicesYou hold urgency, trust, and deep community knowledge. Compleo Advisors helps translate that into structured strategy, compelling communication, and the industry partnerships that drive real progress for patients and families.
Explore advocacy servicesYou help pharmaceutical clients move markets and grow brands. Compleo Advisors works with marketing services organizations to define positioning, clarify go-to-market strategy, and build the market presence that draws the right clients and drives growth.
Explore marketing servicesA diagnostic-first approach
Every engagement begins with diagnostic work. Compleo Advisors studies the business, the brand, and the market: what drives them, what holds them back, and where the real opportunity sits.
Stakeholder insight, market research, and competitive analysis: the clarity that grounds every decision that follows.
Strategy, positioning, and narrative that moves audiences and grows markets.
Execution that moves the market. Creative, campaigns, partnerships, and the work between.
What sets us apart
This is the field we know intimately. Our work is shaped by the dynamics that define the rare disease ecosystem: profound urgency, high scientific complexity, strong collaboration with advocacy, and the high stakes of getting it right the first time.
Clients work directly with senior, strategic experts across every engagement. The thinking is not delegated. The work moves faster, the judgment is sharper, and the relationship stays close.
Compleo Advisors delivers strategy that becomes creative execution, market presence, and the partnerships that drive progress. The work moves from idea to activation without losing intent along the way.
Led by
Kristin built Compleo Advisors to close a critical gap in rare disease: early-stage companies and advocacy organizations doing meaningful work without the strategic and creative support their communities deserve. She brings 25+ years of pharmaceutical and specific rare disease marketing experience, with 20 years leading B2B strategy and commercial execution.
Read her full background